AI-generated summary
The authors report a randomized, placebo-controlled trial of a single session of photobiomodulation therapy in 18 people with chronic non-specific low back pain. They found that serum prostaglandin E2 levels were lower after active treatment than after placebo, with no difference in other inflammatory markers or pain intensity.
- Participants
- 18
- Who or what was studied
- Patients with chronic non-specific low back pain
- Limits stated in the abstract
- The abstract describes a small sample of 18 patients and a single treatment session, and does not report wavelengths or a longer follow-up period.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Placebo-controlled, Confidence interval, Trial registration, Primary outcome. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.